Human Organoids Market Analysis

Product (Pancreas, Kidney, Lungs, Heart, Liver Models)

The global human organoids market is segmented and analyzed for demand and supply by product into pancreas, kidney, lungs, heart, liver models, and others. Out of the six types of irritable bowel syndrome, the kidney segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the increasing number of kidney transplants performed globally as compared to other procedures. As per the statistics by the National Kidney Foundation, there were 121,678 people waiting for lifesaving organ transplants in the U.S. in 2020. Out of these, 100,791 individuals were waiting for kidney transplants. Moreover, there has been a significant growth in kidney-related diseases, which is also projected to contribute to the growth of the segment during the forecast period.

End-user (Biotech & Pharma, Academic & Research Institutes, Hospitals & Diagnostic Centers)

The global human organoids market is also segmented and analyzed for demand and supply by end-user into biotech & pharma industry, academic & research institutes, hospitals & diagnostic centers, and others. Amongst these four segments, the biotech & pharma industry segment is expected to garner a significant share. The growth of the segment is expected on the back of increasing focus of biotech & pharma industry on research and development related to new drug discovery for the treatment of various rare diseases, combined with technological developments in the field of 3D bioprinting.

Our in-depth analysis of the global market includes the following segments: